HCA Healthcare (HCA)
NYSE:HCA
Want to see HCA full AI Analyst Report?
HCA Stock Chart & Stats
$488.00
$3.48(1.13%)
At close: 4:00 PM EST
$488.00
$3.48(1.13%)
Day’s Range― - ―
52-Week Range$330.00 - $556.52
Previous CloseN/A
Volume584.21K
Average Volume (3M)975.50K
Market Cap
$96.08B
Enterprise Value$146.11B
Total Cash (Recent Filing)$940.00M
Total Debt (Recent Filing)$49.84B
Price to Earnings (P/E)16.6
Beta0.32
Next Earnings
Jul 23, 2026EPS Estimate
7.38Next Dividend Ex-DateN/A
Dividend Yield0.61%
Share Statistics
EPS (TTM)7.15
Shares Outstanding221,839,800
10 Day Avg. Volume841,725
30 Day Avg. Volume975,497
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)-17.87
Price to Sales (P/S)1.42
P/FCF Ratio14.00
Enterprise Value/Market Cap1.52
Enterprise Value/Revenue1.91
Enterprise Value/Gross Profit5.48
Enterprise Value/Ebitda9.33
Forecast
1Y Price Target
$523.14Price Target Upside7.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
EPS Forecast (FY)30.19
Revenue Forecast (FY)$78.50B
Bulls Say, Bears Say
Bulls Say
Artificial Intelligence AdoptionManagement frames artificial intelligence as an enterprise capability with dedicated teams and infrastructure expected to deliver durable productivity, revenue integrity, and margin benefits across administrative, operational, and clinical areas.
Capital Return And Cash FlowHCA's strong margins and cash flow enable consistent share repurchases, providing direct capital return to investors and supporting valuation.
Resiliency Program And Cost ControlAnalyst highlights a broad resiliency program of discrete initiatives across revenue, throughput, and costs positioned as an ongoing strategic effort to offset policy and payer headwinds and support margin resilience.
Bears Say
Payor Denials And Insurance Market DisruptionElevated payor denials combined with disruption in marketplace insurance coverage and reduced subsidy-related benefits are expected to pressure volumes and operating revenue.
Valuation And Guidance RiskRich valuation levels and guidance that assumes unusually strong core growth limit upside potential as underlying momentum has slowed and commercial volume growth remains subdued.
Weather And Volume DisruptionWeather-related disruptions are expected to reduce elective and outpatient volumes, modestly pressuring revenue and operating performance.
HCA Healthcare News
HCA FAQ
What was HCA Healthcare’s price range in the past 12 months?
HCA Healthcare lowest stock price was $330.00 and its highest was $556.52 in the past 12 months.
What is HCA Healthcare’s market cap?
HCA Healthcare’s market cap is $96.08B.
When is HCA Healthcare’s upcoming earnings report date?
HCA Healthcare’s upcoming earnings report date is Jul 23, 2026 which is in 81 days.
How were HCA Healthcare’s earnings last quarter?
HCA Healthcare released its earnings results on Apr 24, 2026. The company reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.124 by $0.026.
Is HCA Healthcare overvalued?
According to Wall Street analysts HCA Healthcare’s price is currently Undervalued.
Does HCA Healthcare pay dividends?
HCA Healthcare pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 0.61%. See more information on HCA Healthcare dividends here
What is HCA Healthcare’s EPS estimate?
HCA Healthcare’s EPS estimate is 7.38.
How many shares outstanding does HCA Healthcare have?
HCA Healthcare has 221,839,800 shares outstanding.
What happened to HCA Healthcare’s price movement after its last earnings report?
HCA Healthcare reported an EPS of $7.15 in its last earnings report, beating expectations of $7.124. Following the earnings report the stock price went down -8.769%.
Which hedge fund is a major shareholder of HCA Healthcare?
Currently, no hedge funds are holding shares in HCA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HCA Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$523.14 (7.20% Upside)
$523.14 (7.20% Upside)
Blogger Sentiment
Bullish
HCA Sentiment 86%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 2.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $31.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days >0.1%
Last 30 Days ▲ 0.8%
Last 30 Days ▲ 0.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.64%
12-Months-Change
Fundamentals
Return on Equity
-123.20%
Trailing 12-Months
Asset Growth
2.76%
Trailing 12-Months
Company Description
HCA Healthcare
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
HCA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated a majority of positive operating and financial developments—revenue growth (+4.3%), strong EPS expansion (~11%), robust cash flow (+22%), sizable share repurchases, and a $200M incremental benefit from Medicaid supplemental programs—while acknowledging several meaningful headwinds including a sharp decline in respiratory-driven volumes, a January winter storm (combined ~$180M EBITDA drag), exchange-related revenue pressure (~$150M Q1; $600M–$900M full-year range), margin compression (‑50 bps) and rising denials. Management characterized the respiratory and weather impacts as temporal, reiterated full-year guidance and reaffirmed resiliency and AI-driven cost-efficiency plans. On balance, the company reported core growth and reinforced confidence in its balance sheet and guidance but faces significant payer and volume dynamics to monitor.View all HCA earnings summariesHCA Revenue Breakdown
28.15% National Group
32.68% Atlantic Group
34.98% American Group
4.19% Corporate and other
HCA Stock 12 Month Forecast
Average Price Target
$523.14
▲(7.20% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Encompass Health
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
Currently, No data available
---